99 related articles for article (PubMed ID: 6272442)
1. Effects of suloctidil on platelet survival time following cardiac valve replacement.
Col-de Beys C; Ferrant A; Moriau M
Thromb Haemost; 1981 Aug; 46(2):550-3. PubMed ID: 6272442
[TBL] [Abstract][Full Text] [Related]
2. In vivo effect of suloctidil as an antiplatelet agent.
Stelzer MR; Burns TS; Saunders RN
Thromb Haemost; 1979 May; 41(3):465-74. PubMed ID: 462414
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
Baele G; Bary JL; van Stalle F
Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
[TBL] [Abstract][Full Text] [Related]
4. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
6. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
7. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
[TBL] [Abstract][Full Text] [Related]
8. Studies of suloctidil in experimental thrombosis in baboons.
Hanson SR; Harker LA
Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
[TBL] [Abstract][Full Text] [Related]
9. Platelet survival and function in animals with prosthetic mitral valve: the effect of nafazatrom.
Al-Mondhiry H; Pierce WS; Richenbacher W
Thromb Haemost; 1984 Oct; 52(2):99-101. PubMed ID: 6523440
[TBL] [Abstract][Full Text] [Related]
10. [Valve protheses and anti-vitamin K. Biological study in patients given weak and strong doses of anticoagulants].
Boisseau M; Bricaud H; Emeriau JP; Baudet E; Hourregue H
Arch Mal Coeur Vaiss; 1976 Feb; 69(2):219-21. PubMed ID: 823913
[TBL] [Abstract][Full Text] [Related]
11. Depletion of platelet amine storage granules by the antithrombotic agent, suloctidil.
Mills DC; MacFarlane DE
Thromb Haemost; 1977 Dec; 38(4):1010-7. PubMed ID: 579681
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists.
Sermet A; Aybak M; Ulak G; Güzel C; Denli O
Arzneimittelforschung; 1995 Jan; 45(1):19-21. PubMed ID: 7893263
[TBL] [Abstract][Full Text] [Related]
14. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
15. [Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
Zimmermann R; Hoffrichter A; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E; Barth P
Dtsch Med Wochenschr; 1977 Apr; 102(14):509-12. PubMed ID: 852404
[TBL] [Abstract][Full Text] [Related]
16. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
[TBL] [Abstract][Full Text] [Related]
17. Platelet function, coagulation tests, and cardiopulmonary bypass: lack of correlation between pre-operative and intra-operative whole blood lumiaggregometry and peri-operative blood loss in patients receiving autologous platelet-rich plasma.
Irani MS; Izzat NN; Jones JW
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):428-32. PubMed ID: 8589209
[TBL] [Abstract][Full Text] [Related]
18. Fifteen years' clinical experience with the CarboMedics prosthetic heart valve.
Aagaard J; Tingleff J
J Heart Valve Dis; 2005 Jan; 14(1):82-8. PubMed ID: 15700441
[TBL] [Abstract][Full Text] [Related]
19. [Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part II. Influence of treatment on time of remission and patients survival].
Ochmański W
Przegl Lek; 2008; 65(7-8):321-8. PubMed ID: 19004228
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function.
Whiss PA; Lundahl TH; Bengtsson T; Lindahl TL; Lunell E; Larsson R
Toxicol Appl Pharmacol; 2000 Mar; 163(2):95-104. PubMed ID: 10698667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
